Previous 10 | Next 10 |
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA) on behalf of Cassava stockholders. Our investigation concerns wh...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Hard-hit Cassava Sciences ( SAVA ) continues to move lower. Based on recent headlines, this move may be justified. As confidence in its flagship drug candidate Simulfilam drops further, avoid SAVA stock. Sour...
After lackluster trading the previous day, stocks received significant buying interest on Tuesday, with the Nasdaq jumping 2.2% and the Dow adding almost 500 points. The gains reversed some of the losses posted over the past couple weeks. Homebuilders contributed to Tuesday's rally, following...
Gainers: Checkmate Pharmaceuticals (CMPI) +332%. Sono Group (SEV) +66%. ToughBuilt Industries (TBLT) +55%. Petros Pharmaceuticals (PTPI) +40%. Axsome Therapeutics (AXSM) +25%. Cyren (CYRN) +22%. Super Micro Computer (SMCI) +21%. Pulse Biosciences (PLSE) +18%. Annexon (ANNX) +18%. Olema Pharma...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ToughBuilt Industries (NASDAQ: TBLT ) stock is rocketing higher on Tuesday following the release of the home improvement company’s Q4 2021 earnings report. Source: Cat Act Art / Shutterstock.com The big...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Johnson & Johnson (NYSE: JNJ ) stock is on the move Tuesday as investors react to the company’s earnings report for the first quarter of 2022. Source: Alexander Tolstykh / Shutterstock.com Starting ...
Gainers: Checkmate Pharmaceuticals CMPI +333%. Petros Pharmaceuticals (PTPI) +55%. Axsome Therapeutics AXSM +23%. Avinger (AVGR) +11%. Processa Pharmaceuticals (PCSA) +10%. Losers: Lyra Therapeutics (LYRA) -16%. Diffusion Pharmaceuticals (DFFN) -15...
Alzheimer's drug developer, Cassava Sciences (NASDAQ:SAVA) has lost ~18% in the pre-market Tuesday so far after The New York Times detailed new allegations related to the studies of the company’s experimental therapy, simufilam. The prospects of the therapy pro...
Volatility remains the dominant factor across the equities market, with interest rates rising and growth stocks well underwater so far in 2022. Ground zero for this correction is among “long duration assets”, which includes growth stocks with big hypothetical cash flows down the...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cassava Sciences (NASDAQ: SAVA ) is a clinical-stage biotechnology firm focused on developing drugs for Alzheimer’s disease. The company’s Simufilam drug is in Phase 3 of clinicals trials. At this sta...
News, Short Squeeze, Breakout and More Instantly...
Cassava Sciences, Inc. (NASDAQ: SAVA) is one of today's top gainers. The company's shares have moved 24.9% on the day to $12.59. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...